Toren, P., Kim, S., Johnson, F., & Zoubeidi, A. (2016). Combined AKT and MEK Pathway Blockade in Pre-Clinical Models of Enzalutamide-Resistant Prostate Cancer. PLoS One.
Citación estilo ChicagoToren, Paul, Soojin Kim, Fraser Johnson, and Amina Zoubeidi. "Combined AKT and MEK Pathway Blockade in Pre-Clinical Models of Enzalutamide-Resistant Prostate Cancer." PLoS One 2016.
Cita MLAToren, Paul, Soojin Kim, Fraser Johnson, and Amina Zoubeidi. "Combined AKT and MEK Pathway Blockade in Pre-Clinical Models of Enzalutamide-Resistant Prostate Cancer." PLoS One 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.